The economic burden of breast cancer in Korea from 2007-2010

Young Ae Kim, In Hwan Oh, Seok-Jun Yoon, Hyun Jin Kim, Hye Young Seo, Eun Jung Kim, Yo Han Lee, Jae Hun Jung

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect. Results From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.

Original languageEnglish
Pages (from-to)583-590
Number of pages8
JournalCancer Research and Treatment
Volume47
Issue number4
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Korea
Economics
Breast Neoplasms
Costs and Cost Analysis
Ambulatory Care Facilities
Health Care Costs
Incidence

Keywords

  • Breast neoplasms
  • Cost of illness

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kim, Y. A., Oh, I. H., Yoon, S-J., Kim, H. J., Seo, H. Y., Kim, E. J., ... Jung, J. H. (2015). The economic burden of breast cancer in Korea from 2007-2010. Cancer Research and Treatment, 47(4), 583-590. https://doi.org/10.4143/crt.2014.143

The economic burden of breast cancer in Korea from 2007-2010. / Kim, Young Ae; Oh, In Hwan; Yoon, Seok-Jun; Kim, Hyun Jin; Seo, Hye Young; Kim, Eun Jung; Lee, Yo Han; Jung, Jae Hun.

In: Cancer Research and Treatment, Vol. 47, No. 4, 01.01.2015, p. 583-590.

Research output: Contribution to journalArticle

Kim, YA, Oh, IH, Yoon, S-J, Kim, HJ, Seo, HY, Kim, EJ, Lee, YH & Jung, JH 2015, 'The economic burden of breast cancer in Korea from 2007-2010', Cancer Research and Treatment, vol. 47, no. 4, pp. 583-590. https://doi.org/10.4143/crt.2014.143
Kim, Young Ae ; Oh, In Hwan ; Yoon, Seok-Jun ; Kim, Hyun Jin ; Seo, Hye Young ; Kim, Eun Jung ; Lee, Yo Han ; Jung, Jae Hun. / The economic burden of breast cancer in Korea from 2007-2010. In: Cancer Research and Treatment. 2015 ; Vol. 47, No. 4. pp. 583-590.
@article{e3d3e3553a394f62835591caca0548d9,
title = "The economic burden of breast cancer in Korea from 2007-2010",
abstract = "Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect. Results From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9{\%} to 20.4{\%}. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7{\%} from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6{\%} increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3{\%} to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0{\%}-5{\%}, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.",
keywords = "Breast neoplasms, Cost of illness",
author = "Kim, {Young Ae} and Oh, {In Hwan} and Seok-Jun Yoon and Kim, {Hyun Jin} and Seo, {Hye Young} and Kim, {Eun Jung} and Lee, {Yo Han} and Jung, {Jae Hun}",
year = "2015",
month = "1",
day = "1",
doi = "10.4143/crt.2014.143",
language = "English",
volume = "47",
pages = "583--590",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "4",

}

TY - JOUR

T1 - The economic burden of breast cancer in Korea from 2007-2010

AU - Kim, Young Ae

AU - Oh, In Hwan

AU - Yoon, Seok-Jun

AU - Kim, Hyun Jin

AU - Seo, Hye Young

AU - Kim, Eun Jung

AU - Lee, Yo Han

AU - Jung, Jae Hun

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect. Results From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.

AB - Purpose This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect. Results From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.

KW - Breast neoplasms

KW - Cost of illness

UR - http://www.scopus.com/inward/record.url?scp=84946733366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946733366&partnerID=8YFLogxK

U2 - 10.4143/crt.2014.143

DO - 10.4143/crt.2014.143

M3 - Article

C2 - 25687860

AN - SCOPUS:84946733366

VL - 47

SP - 583

EP - 590

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 4

ER -